Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04112186 · ClinicalTrials.gov registry record · NA
Mindfulness-Oriented Recovery Enhancement (MORE) in Heroin Addiction
A NA study of Opiate Use Disorder, sponsored by Icahn School of Medicine at Mount Sinai.
- Active
- Registry status
- NA
- Development phase
- 157
- Enrollment target
- 1
- Study location
NCT04112186 is a NA study of Opiate Use Disorder that is active but no longer recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 157 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04112186, a NA study of Opiate Use Disorder, is active but no longer recruiting, sponsored by Icahn School of Medicine at Mount Sinai.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 157 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, neuroimaging of reward processing, drug cue reactivity and inhibitory control is used before and immediately after 8 weeks of two types of group therapy in individuals with opioid addiction; clinical outcomes will be assessed before, immediately and three months after treatment. Results could point to factors that track and predict recovery with treatment, offering clinicians markers that can be used for enhancing precision medicine with the goal of reducing morbidity and mortality associated with opiate addiction.
Conditions Studied
Interventions
- BEHAVIORAL Behavioral group therapy #1
- BEHAVIORAL Behavioral group therapy #2
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2020-06-21 |
| Est. Completion | 2031-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04112186
The ClinicalTrials.gov registry entry for NCT04112186 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opiate Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Behavioral group therapy #1 is the first listed.
NCT04112186 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04112186 about?
NCT04112186 is a clinical study titled "Mindfulness-Oriented Recovery Enhancement (MORE) in Heroin Addiction". In this study, neuroimaging of reward processing, drug cue reactivity and inhibitory control is used before and immediately after 8 weeks of two types of group therapy in individuals with opioid addiction; clinical outcomes will be assessed before, immediately and three months after treatment. Resul...
What is the current status of trial NCT04112186?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 157 participants. The study started on 2020-06-21. Estimated completion is 2031-03-31.
What conditions does trial NCT04112186 study?
This clinical trial studies the following conditions: Opiate Use Disorder.
What interventions are being tested in trial NCT04112186?
The interventions under investigation include: Behavioral group therapy #1 (BEHAVIORAL), Behavioral group therapy #2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT04112186?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04112186 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.